Prime Medicine (PRME) Reaches Positive Resolution to Arbitration with Beam Therapeutics
Prime Medicine, Inc. (NASDAQ:PRME) is one of the best strong buy penny stocks to invest in now. Prime Medicine, Inc.
Prime Medicine Inc. (PRME)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 8,348,746 | $30,806,875 | +34% | 0.2% |
| 2. | Balyasny Asset Management Dmitry Balyasny | 3,969,082 | $14,645,913 | -4% | 0.02% |
| 3. | Casdin Capital Eli Casdin | 3,167,175 | $11,686,876 | 0.58% | |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,003,904 | $11,084,406 | +1% | 0.03% |
| 5. | Citadel Investment Group Ken Griffin | 2,054,543 | $7,581,264 | +511% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.30 | 1,500,000 | $4,950,000.00 | 3,262,440 | 2025-08-01 | Filing | |
| $3.30 | 3,030,300 | $9,999,990.00 | 6,230,300 | 2025-08-01 | Filing | |
| $3.30 | 3,030,300 | $9,999,990.00 | 6,230,300 | 2025-08-01 | Filing | |
| $3.30 | 3,030,300 | $9,999,990.00 | 6,230,300 | 2025-08-01 | Filing | |
| $2.52 | 21,000 | $52,829.70 | 20,240,945 | 2025-06-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.97 | 19,003 | $284,495.81 | 0 | 2023-06-21 | Filing | |
| $15.06 | 37,405 | $563,248.23 | 0 | 2023-06-20 | Filing | |
| $15.02 | 6,532 | $98,109.33 | 0 | 2023-06-16 | Filing | |
| $14.92 | 66,659 | $994,325.64 | 0 | 2023-06-15 | Filing | |
| $14.87 | 28,960 | $430,684.43 | 0 | 2023-06-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,562,498 | $61,115,618 | 0.06% | |
| 2. | 9,602,041 | $35,431,531 | 0% | |
| 3. | 7,576,460 | $27,957,137 | 0% | |
| 4. | 4,522,640 | $16,688,542 | 0% | |
| 5. | 3,430,518 | $12,658,612 | 0% |
News See All
12 Best Strong Buy Penny Stocks to Invest In Now
On July 10, Jeremy Siegel, WisdomTree and Wharton School finance professor, appeared on CNBC’s ‘Closing Bell’ to talk about where the markets go from here.
10 Overlooked Penny Stocks to Buy Right Now
Reuters reported on June 30, 2026, that the U.S.
10 Best Penny Stocks to Buy Before They Explode
Penny stocks tend to attract attention when risk appetite improves, and smaller companies start participating in the market rally.
10 Best Penny Stocks to Buy and Hold Under $5
Smaller companies have started to attract more attention on Wall Street.
Prime Medicine (PRME) Focuses on Liver Franchise With $191.4M Cash Runway
Prime Medicine Inc. (NASDAQ:PRME) is one of the best new penny stocks to buy.
10 Best New Penny Stocks to Buy
On March 5, Brian Mulberry, Chief Market Strategist at Zacks Investment Management, appeared on BNN Bloomberg to assess the markets amid global tensions.
Jacob Funds Bets on Prime Medicine (PRME), a Next-Generation Gene Therapy Company
Jacob Funds, a mutual fund company, released its fourth-quarter 2025 investor letter. A copy of the same can be downloaded here.
LifeSci Capital Initiates Prime Medicine (PRME), Highlights One-and-Done Potential in Liver and Lung Diseases
Prime Medicine Inc. (NASDAQ:PRME) is one of the best biotech penny stocks to buy according to analysts.
Prime Medicine, Inc. (PRME) Announces NEJM Publication Of PM359 Data
Prime Medicine, Inc.
Hedge Fund Resource Center